318 related articles for article (PubMed ID: 3909360)
21. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
22. The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia.
Mayer RJ; Weinstein HJ; Coral FS; Rosenthal DS; Frei E
Cancer Treat Rep; 1982 Jul; 66(7):1455-62. PubMed ID: 7046925
[No Abstract] [Full Text] [Related]
23. Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
Thomas ED; Bryant JI; Buckner CD; Clift RA; Fefer A; Fialkow PJ; Funk DD; Neiman PE; Rudolph RH; Slichter SJ; Storb R
Trans Assoc Am Physicians; 1971; 84():248-61. PubMed ID: 4151544
[No Abstract] [Full Text] [Related]
24. Bone marrow graft in acute leukemia [proceedings].
Devergie A; Gluckman E; Marty M; Bussel A
Pathol Biol (Paris); 1978 Jan; 26(1):45. PubMed ID: 358085
[No Abstract] [Full Text] [Related]
25. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
Böhnel J; Stacher A
Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
[No Abstract] [Full Text] [Related]
26. [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
Mathé G; Misset JL; Machover D; Schwarzenberg L; Timus M; Jasmin C; Ribaud P; Musset M
Biomed Pharmacother; 1984; 38(1):13-32. PubMed ID: 6380605
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
Geib KR; Papazian R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
[No Abstract] [Full Text] [Related]
28. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
29. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
Oblon DJ; Weiner RS; Mackin PJ
J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
[No Abstract] [Full Text] [Related]
30. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
31. Overview of the clinical relevance of autologous bone marrow transplantation.
Appelbaum FR; Buckner CD
Clin Haematol; 1986 Feb; 15(1):1-18. PubMed ID: 3516484
[No Abstract] [Full Text] [Related]
32. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
33. Leukaemia and lymphomas in childhood.
McElwain TJ; Smith IE
Trans Med Soc Lond; 1977-1978; 94():63-71. PubMed ID: 298108
[No Abstract] [Full Text] [Related]
34. [Results of allogeneic bone marrow transplantation in leukemia].
Yoshikawa S; Tahara T; Sao H; Yamauchi T; Yoshikawa H; Matsuyama K; Hiraiwa A; Akao Y; Morishima Y; Kodera Y
Rinsho Ketsueki; 1985 Jul; 26(7):1104-12. PubMed ID: 3903257
[No Abstract] [Full Text] [Related]
35. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation in acute leukemia--remaining problems.
Santos GW
Transplant Proc; 1978 Mar; 10(1):173-5. PubMed ID: 345558
[No Abstract] [Full Text] [Related]
38. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
Cheţa D; Micu D; Cheţa N
Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
[No Abstract] [Full Text] [Related]
39. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants.
Champlin RE; Gale RP
Cancer Treat Rep; 1984 Jan; 68(1):145-61. PubMed ID: 6362862
[TBL] [Abstract][Full Text] [Related]
40. Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning.
Champlin RE; Ho WG; Mitsuyasu R; Burnison M; Greenberg P; Holly G; Winston DW; Feig SA; Gale RP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2616-9. PubMed ID: 3547943
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
